JPM vs LDI
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
LDI exhibits severe financial distress, anchored by a Piotroski F-Score of 0/9, indicating a total failure across all fundamental health benchmarks. While the company shows impressive top-line revenue growth of 70.10% YoY, this is offset by chronic unprofitability, a negative ROE of -24.09%, and an alarming Debt/Equity ratio of 15.86. The combination of heavy insider selling by the CEO and a consistent pattern of missing earnings estimates suggests a precarious operational state. The stock is currently a high-risk speculative asset with significant insolvency risks.
Compare Another Pair
Related Comparisons
JPM vs LDI: Head-to-Head Comparison
This page compares JPMorgan Chase & Co. (JPM) and loanDepot, Inc. (LDI) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.